Medpage Today on MSN11 天
FDA Approves New IL-31 Drug for Eczema
The FDA approved nemolizumab (Nemluvio) in combination with prescription topical agents for the treatment of ...
For some people, keeping up with eczema treatments can be difficult, but resources are available to help find relief from the ...
AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a ...
Try these holistic remedies to get relief for irritated skin.
Analysts slashed their price targets for the Massachusetts biotech after ‘messy’ trial results in alopecia and eczema.
KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...
Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations.
Nonspecific anti-inflammatories like steroids might be entirely sidelined for mild-to-moderate chronic hand eczema now that three targeted topical agents are available.
Dec 11 (Reuters) - AnaptysBio (ANAB.O), opens new tab said on Wednesday it would end the development of its eczema drug after it failed to meet the main and secondary goals of a mid-stage trial.
Moisturisers play a key role in healing the skin’s damaged barrier, making them essential for patients with eczema, Prof Lee says. Prescribed topical medications, such as steroid creams ...
Health Minister Mark Butler has struck a deal to secure the place of a “life-changing” eczema treatment on the Pharmaceutical ...